Table 2.
Adverse event at first-line and rechallenge treatment
| Grade | First-line, % |
Rechallenge, % |
|||||||
| 2 | 3 | 4 | 3+4 | 2 | 3 | 4 | 3+4 | ||
| Hematological | |||||||||
| Leukopenia | 2 | 8 | 8 | 80 | 4 | 8 | 7 | 75 | |
| Neutropenia | 1 | 6 | 11 | 85 | 1 | 9 | 4 | 65 | |
| Anemia | 2 | 1 | 0 | 5 | 1 | 0 | 0 | 0 | |
| Thrombocytopenia | 2 | 3 | 2 | 25 | 3 | 2 | 0 | 10 | |
| Febrile neutropenia | 0 | 8 | 0 | 40 | 0 | 3 | 0 | 15 | |
| Nonhematological | |||||||||
| Anorexia | 3 | 3 | 0 | 15 | 4 | 0 | 0 | 0 | |
| Nausea/vomit | 3 | 1 | 0 | 5 | 2 | 0 | 0 | 0 | |
| Diarrhea | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Fatigue | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |
| Edema | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Increased AST/ALT | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Increased creatinine | 2 | 1 | 0 | 5 | 1 | 0 | 0 | 0 | |